• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Medtronic ticks up on Street-beating Q4, 28% profit surge

Medtronic ticks up on Street-beating Q4, 28% profit surge

May 22, 2012 By MassDevice staff

MassDevice.com news

Medtronic (NYSE:MDT) shares are down a tick this morning after the medical device bellwether reported a 28% surge in 4th-quarter profits on its way to beating The Street’s earnings-per-share forecast by a penny.*

The Fridley, Minn-based company posted profits of $991.0 million, or 95¢ per share, on sales of $4.30 billion during the 3 months ended April 27. Adjusted to exclude 1-time items, EPS reached 99¢, a penny above analysts’ expectations.

Sign up to get our free newsletters delivered straight to your inbox

Medtronic logged fiscal 2012 profits of $3.62 billion, or $3.41 per share, on sales of $16.18 billion, representing a bottom-line gain of 16.8% and a 4.4% revenue boost. Full-year adjusted EPS were $3.46, 2¢ above expectations on The Street.

"Our growth was broad-based across our businesses and geographies, including strong U.S. launches of the Resolute Integrity drug-eluting stent and RestoreSensor spinal cord stimulator and strong growth in emerging markets. As we continue to focus on innovation, globalization, and execution, I see many opportunities for improved growth," chairman & CEO Omar Ishrak said in prepared remarks. "We are beginning to gain momentum worldwide and are optimistic about our ability to improve long-term growth as we expand globally and identify new opportunities to deliver economic value to the changing health care system."

Medtronic said it expects to post FY2013 sales growth of between 2% and 4% on a constant-currency basis, with diluted EPS of $3.62-$3.70, "which implies EPS growth of 5% to 7%," according to a press release.

The news sent MDT shares up 0.7% to a $37.97 open today, compared with yesterday’s close of $37.70, but shares had fallen to $37.25 apiece as of about 11:45 this morning, down 1.2%.

*Correction, May 22, 2012: Due to a reporter’s error, this article originally mis-stated the extent of MDT’s share price gain between close of market May 21 and the market’s open today. Return to the corrected sentence.

Filed Under: MassDevice Earnings Roundup, News Well Tagged With: 2012, Q1

More recent news

  • Imperative Care has positive stroke treatment study results
  • Medtronic enrolls first patient in study for Onyx liquid embolic system
  • Intuitive demonstrates remote telesurgery capabilities with da Vinci 5
  • BD issues voluntary recall on certain Alaris infusion pump modules
  • CVRx announces Medicare win for Barostim therapy

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy